Read original release here January 17, 2019 at 7:05 AM EST DARTMOUTH, Nova Scotia, Jan. 17, 2019 (GLOBE NEWSWIRE) — IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that the first patient has been treated in the Phase 1 trial evaluating neoepitopes formulated in the Company’s proprietary DPX delivery platform in patients with ovarian…

Read the original article here.  Halifax-based Adaptiiv has announced major new clients in Hong Kong and the U.S. as the young medical technology company expands its customer base to seven countries. The company – which uses 3D printing technology to improve radiation therapy in cancer treatment – said Monday it had signed a deal to sell its…

See original story here It would not be surprising to hear about someone who has made a significant impact in TED Talks and at national and international conferences, or even someone whose research and contributions to the scientific community has garnered them praise and meetings with the national Chief Science Advisor, Dr. Mona Nemer, Canadian…

See original story here CORALVILLE, Iowa, April 12, 2018 /PRNewswire/ — CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, and Adaptiiv (formerly 3D Bolus), the definitive 3D technology platform for radiation therapy, are excited to announce their collaboration in bringing more personalized medical devices to the market. This initiative aligns with the…

2015 © Copyright - Bionova